State of Wisconsin Investment Board
ALLO icon

State of Wisconsin Investment Board’s Allogene Therapeutics ALLO Stock Holding History

State of Wisconsin Investment Board’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14,919
Closed -$31.8K – 2244
2024
Q4 		$31.8K Buy
14,919
+2,049
+16% +$5.05K ﹤0.01% 2245
2024
Q3 		$36K Hold
12,870
– – ﹤0.01% 2251
2024
Q2 		$30K Buy
+12,870
New +$38K ﹤0.01% 2271
2024
Q1 		– Sell
-25,729
Closed -$82.6K – 2219
2023
Q4 		$82.6K Sell
25,729
-159,319
-86% -$452K ﹤0.01% 2277
2023
Q3 		$587K Buy
185,048
+109,245
+144% +$479K ﹤0.01% 1664
2023
Q2 		$377K Sell
75,803
-4,061
-5% -$22K ﹤0.01% 1916
2023
Q1 		$395K Sell
79,864
-2,499
-3% -$16K ﹤0.01% 1967
2022
Q4 		$518K Sell
82,363
-5,281
-6% -$48.9K ﹤0.01% 1883
2022
Q3 		$947K Sell
87,644
-69,317
-44% -$942K ﹤0.01% 1569
2022
Q2 		$1.79M Buy
156,961
+9,761
+7% +$86.6K ﹤0.01% 1396
2022
Q1 		$1.34M Buy
147,200
+59,200
+67% +$617K ﹤0.01% 1585
2021
Q4 		$1.31M Hold
88,000
– – ﹤0.01% 1368
2021
Q3 		$2.26M Hold
88,000
– – ﹤0.01% 1255
2021
Q2 		$2.29M Buy
88,000
+15,500
+21% +$442K ﹤0.01% 1253
2021
Q1 		$2.56M Sell
72,500
-3,100
-4% -$105K 0.01% 1185
2020
Q4 		$1.91M Sell
75,600
-2,300
-3% -$75K ﹤0.01% 1216
2020
Q3 		$2.94M Hold
77,900
– – 0.01% 1085
2020
Q2 		$3.34M Buy
77,900
+18,000
+30% +$651K 0.01% 1006
2020
Q1 		$1.16M Buy
59,900
+1,700
+3% +$40.5K ﹤0.01% 1173
2019
Q4 		$1.51M Hold
58,200
– – ﹤0.01% 1170
2019
Q3 		$1.59M Buy
58,200
+26,200
+82% +$746K ﹤0.01% 1054
2019
Q2 		$859K Buy
+32,000
New +$892K ﹤0.01% 1178

Other funds holding ALLO

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State of Wisconsin Investment Board's ALLO Position: Q1 2025 in Review

State of Wisconsin Investment Board sold out of Allogene Therapeutics (ALLO) in Q1 2025, closing a stake of 14,919 shares — an estimated $31.8K sold.

State of Wisconsin Investment Board first reported a position in ALLO in Q2 2019 and held it in 22 quarters. The position peaked at $3.34M in Q2 2020. 170 funds tracked by Wall St. Rank hold ALLO as of Q1 2025.

  • State of Wisconsin Investment Board reported no remaining Allogene Therapeutics position as of Q1 2025 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 14,919 Allogene Therapeutics shares in Q1 2025, an estimated $31.8K.
  • State of Wisconsin Investment Board first reported a position in Allogene Therapeutics in Q2 2019 and held it in 22 quarters.
  • State of Wisconsin Investment Board's Allogene Therapeutics position peaked at $3.34M in Q2 2020.
  • 170 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q1 2025.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2025, filed 15 May 2025.